INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$2.7M

$2,697,124

View Raw Line-Items

Live Feed: 2026-04-02

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
TARS S Tarsus Pharmaceuticals, Inc. Azamian Bobak R. • CEO Sell to CoverΔOwn -26.4% 2026-03-19 $801,588 View Form 4 →
TARS	Tarsus Pharmaceuticals, Inc.	Azamian Bobak R. CEO Sell to CoverΔOwn -26.4%	2026-03-19	$801,588	S	Form 4
TARS S Tarsus Pharmaceuticals, Inc. Azamian Bobak R. • CEO Sell to CoverΔOwn -20.4% 2026-03-18 $801,640 View Form 4 →
TARS	Tarsus Pharmaceuticals, Inc.	Azamian Bobak R. CEO Sell to CoverΔOwn -20.4%	2026-03-18	$801,640	S	Form 4
TARS S Tarsus Pharmaceuticals, Inc. Azamian Bobak R. • CEO Sell to CoverΔOwn -16.1% 2026-03-17 $761,676 View Form 4 →
TARS	Tarsus Pharmaceuticals, Inc.	Azamian Bobak R. CEO Sell to CoverΔOwn -16.1%	2026-03-17	$761,676	S	Form 4
TARS S Tarsus Pharmaceuticals, Inc. Azamian Bobak R. • CEO 10b5-1 Sell 2025-09-24 $332,220 View Form 4 →
TARS	Tarsus Pharmaceuticals, Inc.	Azamian Bobak R. CEO 10b5-1 Sell	2025-09-24	$332,220	S	Form 4